Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NRC	NATIONAL RESEARCH CORP	$345.07M	67.80%	12.00%	28.38%	27.80%	8.48	0.53	62.10%	11.80%	19.82%
INGN	INOGEN INC	$187.32M	-13.20%	-8.30%	-10.78%	-25.80%	0.56	3.14	44.80%	-7.30%	-7.52%
LEGN	LEGEND BIOTECH CORP	$5.59B	-23.40%	-14.30%	-15.74%	-27.80%	0.69	2.87	60.60%	-26.40%	-22.16%
ALDX	ALDEYRA THERAPEUTICS INC	$303.82M	-72.20%	-47.90%	-83.73%	-130.90%	0.58	2.72	N/A	N/A	N/A
OKYO	OKYO PHARMA LTD	$84.40M	N/A	-180.40%	127.79%	102.70%	-1.66	0.40	N/A	N/A	N/A
TEM	TEMPUS AI INC	$12.18B	-68.00%	-12.80%	-9.38%	-15.10%	3.49	3.28	61.70%	-18.40%	-16.39%
SCYX	SCYNEXIS INC	$24.59M	-54.30%	-37.40%	-58.43%	-52.10%	0.40	5.75	100.00%	-862.90%	-849.01%
AYTU	AYTU BIOPHARMA INC	$21.29M	-48.50%	-10.70%	-16.64%	-142.30%	4.39	1.23	67.60%	-20.50%	-15.41%
SRDX	SURMODICS INC	$594.99M	-17.30%	-11.60%	-7.42%	-12.70%	0.48	5.14	73.40%	-16.30%	-9.11%
XGN	EXAGEN INC	$204.19M	-138.20%	-36.90%	-30.92%	-39.40%	2.46	4.08	59.90%	-29.90%	-24.27%
LFCR	LIFECORE BIOMEDICAL INC	$298.23M	N/A	N/A	N/A	N/A	-18.83	2.80	N/A	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$429.67M	35.30%	31.10%	46.88%	213.10%	0.14	9.17	76.30%	43.20%	56.27%
ATRA	ATARA BIOTHERAPEUTICS INC	$99.21M	-41.80%	39.30%	225.66%	52.50%	-1.82	1.02	81.60%	15.40%	17.99%
NEO	NEOGENOMICS INC	$1.34B	-13.00%	-7.60%	-8.55%	-15.20%	0.64	3.91	43.50%	-16.00%	-15.40%
STTK	SHATTUCK LABS INC	$118.97M	-73.80%	-66.00%	-57.79%	-212.60%	0.08	17.00	100.00%	-5,489.50%	-5,489.50%
OFIX	ORTHOFIX MEDICAL INC	$592.01M	-25.60%	-14.10%	-13.42%	-17.40%	0.88	2.47	68.30%	-14.60%	-11.03%
INBX	INHIBRX BIOSCIENCES INC	$1.15B	-137.80%	-76.30%	-91.16%	-390.10%	2.09	4.98	100.00%	-11,692.40%	-11,275.86%
DVA	DAVITA INC	$8.51B	-283.90%	4.40%	11.16%	8.80%	-28.35	1.36	32.00%	5.80%	12.19%
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$486.07M	-289.50%	-53.70%	-66.93%	-45.80%	21.25	6.24	25.40%	-325.80%	-320.36%
AGEN	AGENUS INC	$147.60M	N/A	-16.70%	-46.53%	346.20%	-1.88	0.47	98.90%	-33.10%	23.19%
NMTC	NEUROONE MEDICAL TECHNOLOGIES CORP	$34.45M	-163.40%	-78.70%	-56.81%	-242.80%	0.32	7.13	70.10%	-55.40%	-55.42%
UNH	UNITEDHEALTH GROUP INC	$291.55B	18.60%	5.70%	12.74%	21.70%	2.19	0.82	19.70%	4.00%	5.85%
JANX	JANUX THERAPEUTICS INC	$1.76B	-10.20%	-9.80%	-10.22%	-11.40%	0.05	35.86	100.00%	-1,019.00%	-1,018.95%
ADMA	ADMA BIOLOGICS INC	$3.70B	54.00%	39.40%	32.05%	35.70%	0.32	7.13	54.70%	42.90%	33.60%
TECH	BIO-TECHNE CORP	$9.25B	3.90%	3.00%	4.82%	8.70%	0.29	4.22	65.40%	6.40%	9.43%
LNTH	LANTHEUS HOLDINGS INC	$3.52B	14.80%	8.00%	13.60%	22.30%	1.03	2.67	62.20%	11.00%	17.19%
QDEL	QUIDELORTHO CORP	$1.45B	-43.60%	-18.90%	-19.75%	-20.80%	1.79	1.78	47.20%	-43.50%	-35.70%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.89B	11.00%	5.90%	9.90%	23.40%	0.89	3.70	56.10%	18.10%	29.49%
CSTL	CASTLE BIOSCIENCES INC	$976.36M	-2.70%	-2.30%	-3.70%	-5.70%	0.21	6.47	79.90%	-3.60%	-5.46%
PYPD	POLYPID LTD	$56.20M	-312.80%	-120.70%	-134.93%	-203.00%	0.84	2.28	N/A	N/A	N/A
ACHC	ACADIA HEALTHCARE COMPANY INC	$1.48B	3.50%	1.70%	4.43%	4.70%	1.00	1.44	34.40%	3.30%	7.99%
CVAC	CUREVAC NV	$1.19B	29.20%	25.10%	35.70%	90.50%	0.18	6.17	94.80%	37.90%	43.41%
RVTY	REVVITY INC	$10.51B	3.10%	1.90%	3.38%	7.80%	0.65	1.75	55.30%	8.40%	13.10%
ICLR	ICON PLC	$12.38B	6.30%	3.60%	6.18%	18.50%	0.77	1.06	28.10%	7.40%	10.13%
GH	GUARDANT HEALTH INC	$11.89B	N/A	-29.30%	-37.91%	-23.20%	-4.60	3.50	63.80%	-44.20%	-43.68%
CGEN	COMPUGEN LTD	$153.40M	-53.60%	-25.40%	-35.53%	-123.40%	1.23	4.38	7.40%	-400.10%	-399.26%
MDGL	MADRIGAL PHARMACEUTICALS INC	$12.02B	-41.50%	-26.20%	-27.97%	-32.00%	1.18	3.44	95.30%	-39.00%	-36.67%
LXEO	LEXEO THERAPEUTICS INC	$659.81M	-90.50%	-70.90%	-82.85%	-112.40%	0.19	7.40	N/A	N/A	N/A
LYEL	LYELL IMMUNOPHARMA INC	$359.22M	-96.70%	-76.00%	-86.59%	-101.30%	0.24	10.30	100.00%	-957,823.50%	-957,823.53%
RAPT	RAPT THERAPEUTICS INC	$804.72M	-61.80%	-54.70%	-69.33%	-107.60%	0.09	12.04	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$12.79B	N/A	-82.20%	-86.24%	-30.80%	-1.51	3.88	95.80%	-225.30%	-190.53%
CHEK	CHECK-CAP LTD	$11.56M	-226.20%	-198.10%	1,809.55%	-390.80%	-1.26	0.15	N/A	N/A	N/A
XNCR	XENCOR INC	$1.07B	-20.40%	-14.50%	-12.25%	-9.80%	0.39	6.00	100.00%	-87.10%	-63.85%
UPB	UPSTREAM BIO INC	$1.33B	-28.80%	-28.10%	-32.23%	-40.80%	0.03	32.67	100.00%	-4,386.40%	-4,366.77%
RPTX	REPARE THERAPEUTICS INC	$70.93M	-57.60%	-50.00%	-62.05%	-145.40%	0.10	10.71	100.00%	-608.30%	-601.83%
HROW	HARROW INC	$1.51B	-9.00%	-1.40%	6.67%	9.40%	6.73	2.72	74.60%	-2.00%	7.95%
NVO	NOVO NORDISK A S	$214.44B	67.00%	21.30%	47.46%	56.40%	2.02	0.78	82.00%	32.90%	41.80%
TCRX	TSCAN THERAPEUTICS INC	$62.42M	-73.90%	-45.10%	-59.97%	-67.10%	0.82	6.44	100.00%	-1,693.00%	-1,659.11%
MLYS	MINERALYS THERAPEUTICS INC	$3.23B	-48.20%	-45.80%	-29.73%	-83.20%	0.04	25.50	N/A	N/A	N/A
ATR	APTARGROUP INC	$7.78B	16.00%	8.90%	15.64%	22.00%	0.84	1.19	38.10%	11.50%	15.38%
INMD	INMODE LTD	$896.28M	23.00%	20.40%	16.70%	23.30%	0.12	9.75	78.80%	41.00%	30.52%
ASTH	ASTRANA HEALTH INC	$1.21B	1.30%	0.60%	4.39%	9.60%	2.17	1.40	10.30%	0.30%	2.43%
EOLS	EVOLUS INC	$468.00M	N/A	-26.20%	-24.65%	-22.30%	-8.62	2.02	65.80%	-20.50%	-13.13%
PHAT	PHATHOM PHARMACEUTICALS INC	$1.04B	N/A	-94.40%	-138.80%	-37.00%	-1.57	2.23	87.20%	-186.50%	-138.77%
UNCY	UNICYCIVE THERAPEUTICS INC	$121.86M	-184.40%	-95.50%	-89.14%	368.10%	0.35	3.83	N/A	N/A	N/A
ACRS	ACLARIS THERAPEUTICS INC	$273.03M	-102.80%	-72.40%	-94.51%	-99.10%	0.46	3.93	4.00%	-900.00%	-900.01%
INSM	INSMED INC	$41.21B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
TTRX	TURN THERAPEUTICS INC	$117.78M	N/A	N/A	N/A	N/A	7.53	1.43	N/A	N/A	N/A
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$6.23B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
RLMD	RELMADA THERAPEUTICS INC	$289.67M	-269.50%	-205.20%	-579.92%	-296.10%	0.57	2.86	N/A	N/A	N/A
TAK	TAKEDA PHARMACEUTICAL CO LTD	$45.47B	0.50%	0.20%	3.00%	4.50%	1.03	1.37	64.60%	0.70%	8.37%
QIPT	QUIPT HOME MEDICAL CORP	$106.00M	-9.80%	-4.20%	-2.31%	-2.70%	1.30	1.15	18.10%	-4.50%	-1.78%
SLN	SILENCE THERAPEUTICS PLC	$322.29M	N/A	-38.10%	-52.83%	-97.50%	-0.98	7.69	90.50%	-255.10%	-261.96%
TWST	TWIST BIOSCIENCE CORP	$1.62B	-18.40%	-13.80%	-15.21%	-26.50%	0.35	3.90	49.20%	-23.50%	-23.36%
ABUS	ARBUTUS BIOPHARMA CORP	$869.30M	-50.20%	-37.60%	-45.57%	-57.70%	0.26	18.80	100.00%	-289.40%	-288.70%
USPH	U S PHYSICAL THERAPY INC	$1.09B	9.00%	3.80%	6.82%	15.50%	0.82	1.20	18.70%	5.90%	9.71%
CRBU	CARIBOU BIOSCIENCES INC	$186.00M	-80.80%	-62.70%	-94.14%	-69.20%	0.38	5.54	100.00%	-1,690.40%	-1,690.54%
ABVC	ABVC BIOPHARMA INC	$70.96M	-64.10%	-27.50%	-27.59%	-43.10%	0.55	0.63	100.00%	-515.90%	-507.22%
RDNT	RADNET INC	$5.80B	-1.30%	-0.40%	2.01%	2.00%	2.22	1.88	11.40%	-0.60%	3.15%
HRTX	HERON THERAPEUTICS INC	$201.70M	N/A	-5.70%	-6.97%	-4.50%	15.73	2.56	73.90%	-8.80%	-7.15%
TDOC	TELADOC HEALTH INC	$1.23B	-15.60%	-7.00%	-9.24%	-19.60%	1.07	2.70	69.80%	-8.80%	-9.04%
NBY	NOVABAY PHARMACEUTICALS INC	$129.79M	113.90%	54.80%	159.05%	529.50%	1.67	2.00	54.60%	114.60%	114.59%
COSM	COSMOS HEALTH INC	$25.21M	-74.30%	-30.50%	-53.66%	-46.10%	2.00	0.99	11.40%	-31.00%	-27.78%
NUVB	NUVATION BIO INC	$1.67B	-55.00%	-38.10%	-39.44%	-42.00%	0.85	8.48	54.30%	-813.10%	-786.53%
CGC	CANOPY GROWTH CORP	$366.15M	-67.00%	-38.00%	-38.91%	-41.30%	0.45	5.50	26.80%	-138.50%	-138.08%
URGN	UROGEN PHARMA LTD	$1.11B	N/A	-71.00%	-102.36%	-74.20%	-2.60	3.99	88.00%	-170.60%	-151.45%
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.71B	-67.70%	-47.50%	-54.43%	-51.00%	0.49	10.57	100.00%	-1,618.00%	-1,521.18%
IONS	IONIS PHARMACEUTICALS INC	$11.59B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
TPST	TEMPEST THERAPEUTICS INC	$40.27M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
CTEV	CLARITEV CORP	$714.90M	N/A	-6.70%	-1.64%	-1.60%	-50.00	1.21	74.70%	-35.90%	-8.25%
FGEN	FIBROGEN INC	$35.15M	-126.40%	124.20%	213.12%	161.40%	-7.02	3.71	82.70%	-182.60%	-182.34%
CCRN	CROSS COUNTRY HEALTHCARE INC	$364.62M	-3.80%	-2.80%	-3.08%	-6.80%	0.32	3.45	20.20%	-1.40%	-1.23%
SGRY	SURGERY PARTNERS INC	$1.98B	-9.80%	-2.20%	2.88%	3.70%	2.78	1.88	23.90%	-5.20%	6.44%
DARE	DARE BIOSCIENCE INC	$26.58M	N/A	-82.70%	-183.21%	165.90%	9.76	1.18	-44.70%	30,568.80%	30,568.80%
VRCA	VERRICA PHARMACEUTICALS INC	$37.30M	N/A	-59.00%	-143.79%	-62.50%	-3.40	1.26	91.40%	-84.40%	-55.91%
KURA	KURA ONCOLOGY INC	$975.03M	-65.40%	-30.60%	-40.35%	-41.40%	1.68	5.12	100.00%	-208.50%	-204.82%
PLRZ	POLYRIZON LTD	$4.48M	-12.40%	-11.70%	-18.72%	-3,440.00%	0.02	44.04	N/A	N/A	N/A
CBIO	CRESCENT BIOPHARMA INC	$180.88M	-84.60%	-71.60%	-46.53%	693.40%	0.19	6.63	N/A	N/A	N/A
MGX	METAGENOMI INC	$65.33M	-43.20%	-31.10%	-41.23%	-34.60%	0.39	6.42	100.00%	-287.10%	-291.26%
CRON	CRONOS GROUP INC	$938.09M	3.40%	3.10%	-0.57%	-2.60%	0.04	22.46	43.40%	27.30%	-4.88%
PVLA	PALVELLA THERAPEUTICS INC	$990.95M	-68.50%	-45.50%	-49.43%	433.60%	0.73	6.49	100.00%	66,162.30%	52,807.55%
COYA	COYA THERAPEUTICS INC	$122.83M	-57.40%	-49.70%	-67.50%	-49,060.60%	0.17	8.73	100.00%	-462.30%	-480.32%
ANIX	ANIXA BIOSCIENCES INC	$137.92M	-63.10%	-59.20%	-71.32%	-71.90%	0.14	8.45	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.88B	-73.50%	-57.60%	-70.35%	-174.50%	0.64	5.66	100.00%	-1,266.00%	-1,264.37%
VTYX	VENTYX BIOSCIENCES INC	$660.07M	-48.10%	-43.90%	-53.25%	-50.70%	0.11	17.86	N/A	N/A	N/A
HCAT	HEALTH CATALYST INC	$160.21M	-30.30%	-14.60%	-18.48%	-35.40%	0.77	1.88	46.50%	-34.10%	-29.19%
BNGO	BIONANO GENOMICS INC	$15.47M	-86.40%	-49.80%	-68.74%	-66.70%	0.59	2.12	46.00%	-134.40%	-134.24%
BDSX	BIODESIX INC	$63.65M	-504.40%	-43.90%	-45.53%	-31.60%	-52.52	1.84	79.80%	-49.30%	-40.07%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$903.54M	-32.10%	-28.20%	-31.77%	-35.90%	0.14	8.68	89.40%	-113.50%	-108.69%
XLO	XILIO THERAPEUTICS INC	$37.12M	-857.90%	-52.90%	-75.67%	265.00%	-17.52	2.20	100.00%	-183.90%	-183.90%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	623	+2.20%	+5.71%	+6.50%	-48.18%	280.44x	5.12x	-28.91%	-10.34%	-18.67%	+51.40%	Strong Buy
Diagnostics & Research	57	-0.54%	-0.05%	+7.81%	+13.10%	24.30x	4.32x	-0.69%	+6.67%	+14.18%	+6.65%	Strong Buy
Drug Manufacturers - General	20	+0.07%	+7.27%	+13.49%	+21.54%	46.21x	6.69x	+109.31%	+12.14%	+20.15%	+1.52%	Hold
Drug Manufacturers - Specialty & Generic	77	+0.26%	+0.39%	-1.67%	-13.53%	25.64x	2.17x	+10.61%	+3.75%	+7.10%	+39.12%	Strong Buy
Healthcare Plans	10	-1.12%	-1.70%	-11.49%	-30.09%	43.50x	1.99x	+12.29%	+3.80%	+9.27%	+22.65%	Buy
Health Information Services	55	-0.49%	-3.70%	-3.58%	-54.29%	41.06x	4.01x	+7.76%	+4.89%	+7.21%	+35.44%	Strong Buy
Medical Care Facilities	48	-0.85%	-1.86%	+0.24%	-21.33%	14.89x	5.29x	-83.73%	+7.67%	+16.73%	+20.32%	Buy
Medical Devices	138	-0.60%	+2.09%	+2.40%	-33.58%	26.64x	3.95x	+12.09%	+7.33%	+8.47%	+25.75%	Strong Buy
Medical Distribution	11	-0.70%	-0.56%	+11.83%	+39.03%	30.11x	433.03x	-34.73%	+3.63%	+22.01%	+4.72%	Buy
Medical Instruments & Supplies	56	-1.36%	-0.06%	+3.18%	-38.36%	198.50x	3.64x	+10.92%	+8.99%	+11.88%	+19.69%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 39, which is 13 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Pediatrix Medical Group has seen its stock return 56.84% over the past year, overperforming other healthcare stocks by 89 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -7.85% from Pediatrix Medical Group's current stock price of $23.15.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 51.9% over the past year, overperforming other healthcare stocks by 84 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $46.67, an upside of 1.49% from Collegium Pharmaceutical's current stock price of $45.98.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Collegium Pharmaceutical, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 27, which is 1 points higher than the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 200.39% over the past year, overperforming other healthcare stocks by 232 percentage points.

Indivior has an average 1 year price target of $32.50, an upside of 6.59% from Indivior's current stock price of $30.49.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.09%, which is 11 percentage points higher than the healthcare sector average of 2.04%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.84%, which is 9 percentage points higher than the healthcare sector average of 2.04%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.99%, which is 7 percentage points higher than the healthcare sector average of 2.04%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.35% in the last day, and up 2.29% over the last week. Leap Therapeutics was the among the top gainers in the healthcare sector, gaining 368.04% yesterday.

Leap Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.12% in the past year. It has overperformed other stocks in the healthcare sector by 35 percentage points.

2. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -50.82% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -28.31% in the past year. It has overperformed other stocks in the healthcare sector by 4 percentage points.

Are healthcare stocks a good buy now?

54.66% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 28.56% over the next year.

8.08% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.89% of healthcare stocks are rated B (Buy), 46.72% are rated C (Hold), 24.47% are rated D (Sell), and 9.84% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 84.32x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.